Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

Phoenix ,  USA 9 - 12 October 2026

Heart Failure Society of America (HFSA 2026)

Presentation schedule and materials
Sunday, 11 October 2026
13:15  - 13:45
MST
661
POSTER
Inflammatory biomarkers in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) treated with coramitug: post hoc analysis of a phase 2 randomized trial
Nowell M Fine1,2; Wansuk Choi3; Nelson Ferreira4; Bjarke Follin4; Marianna Fontana5; Mathew S Maurer6; Uzoma Obiaka3; Julie L Rosenthal7; Peter-Paul Zwetsloot8,9; Kenichi Tsujita10
MATERIALS AVAILABLE
fine-et-al-attr-inflammation-bm-poster-25-sep-26-for-sh
Poster
Monday, 12 October 2026
09:50  - 09:57
MST
SHORT ORAL PRESENTATION
Prevalence of Cardiovascular Inflammation and Associated Patient Characteristics and Biomarker Profiles Across the Heart Failure Spectrum in the United States: Results From the POSEIDON Study
Marat Fudim, MD, MHS1,2; Johanna P. Contreras, MD, MSc3; Homam Ibrahim, MD4; Pablo E. Pergola, MD, PhD5; Ashley Goss, PhD6; Marco Petti, MD6; Jeffrey R. Skaar, PhD6; Udi Fainberg, MD6; Matthew Budoff, MD7
MATERIALS AVAILABLE
poseidon-hfsa-2026-plenary-presentation
Slide
Keywords
Cardiovascular Disease
Cardiology
HFSA